A.R.T. Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

A.R.T. Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-8,663	Closed	-$668K	–	1282
2018 Q3	$668K	Buy	8,663 +5,900	+214%	+$475K	0.03%	731
2018 Q2	$232K	Sell	2,763 -5,124	-65%	-$447K	0.01%	1187
2018 Q1	$644K	Sell	7,887 -18,448	-70%	-$1.43M	0.03%	844
2017 Q4	$1.5M	Buy	+26,335	New	+$1.66M	0.07%	472
2016 Q3	–	Sell	-10,202	Closed	-$427K	–	632
2016 Q2	$427K	Sell	10,202 -19,000	-65%	-$938K	0.02%	856
2016 Q1	$1.19M	Buy	+29,202	New	+$1.25M	0.05%	515
2015 Q2	–	Sell	-21,848	Closed	-$2.06M	–	1448
2015 Q1	$2.06M	Sell	21,848 -33,529	-61%	-$3.76M	0.07%	385
2014 Q4	$6.2M	Buy	+55,377	New	+$4.94M	0.23%	96

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

A.R.T. Advisors's AGIO Position: Q4 2018 in Review

A.R.T. Advisors sold out of Agios Pharmaceuticals (AGIO) in Q4 2018, closing a stake of 8,663 shares — an estimated $668K sold.

A.R.T. Advisors first reported a position in AGIO in Q4 2014 and held it in 8 quarters. The position peaked at $6.2M in Q4 2014. 196 funds tracked by Wall St. Rank hold AGIO as of Q4 2018.

A.R.T. Advisors reported no remaining Agios Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
A.R.T. Advisors sold 8,663 Agios Pharmaceuticals shares in Q4 2018, an estimated $668K.
A.R.T. Advisors first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 8 quarters.
A.R.T. Advisors's Agios Pharmaceuticals position peaked at $6.2M in Q4 2014.
196 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2018.

Based on A.R.T. Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.